Please use this identifier to cite or link to this item:
Title: Design and modeling of Pharmaceutical polymorphic crystallization processes
Keywords: polymorphism; pseudo-polymorphism; concentration feedback control; selective crystallization; monotropic; enantiotropic
Issue Date: 16-Jun-2009
Citation: KEE CHUNG SHEN, NICHOLAS (2009-06-16). Design and modeling of Pharmaceutical polymorphic crystallization processes. ScholarBank@NUS Repository.
Abstract: This research project focuses on the crystallization of polymorphic compounds. With increasing structural complexity of high value-added products, multiple polymorphs are more frequently encountered in the pharmaceutical industry; it is pertinent to establish controlled crystallization for the intended polymorph with its expected physical properties. The goal of this work is to design, control, and model polymorphic crystallization using recent advances in sensor technologies including Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectroscopy, laser backscattering, and video microscopy. A systematic methodology using concentration feedback control is presented for the selective crystallization of the metastable form of L-glutamic acid, a monotropic dimorph system, and L-phenylalanine, an enantiotropic pseudo-dimorph system. For the latter, a semi-automated procedure for measuring the solubility of both enantiotropes is developed based on the various in situ measurements. Additionally, a process model for the crystallization of L-phenylalanine is developed with kinetics estimated for the anhydrate and monohydrate forms using in situ ATR-FTIR spectroscopy and laser backscattering.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Nicholas_Kee _Thesis.pdf8.47 MBAdobe PDF



Page view(s)

checked on Feb 3, 2019


checked on Feb 3, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.